Tolremo Therapeutics
Tolremo Therapeutics is a cancer Resistance Prevention.
8
Funding Rounds
$81.9m
Money raised
Funding
Funding series
Funding Series Analysis
The company Tolremo Therapeutics has raised a total of $81.9m in funding over 8 rounds.
Key Insights:
- TOLREMO therapeutics September 2023 Series A Funding Round: $20m
- TOLREMO therapeutics September 2023 Series A Funding Round: $20m
- TOLREMO therapeutics June 2020 Series A Funding Round: $5.1m
- TOLREMO therapeutics June 2020 Series A Funding Round: $5.1m
- TOLREMO therapeutics September 2018 Series A Funding Round: $9.9m
- TOLREMO therapeutics September 2018 Series A Funding Round: $9.9m
- Tolremo Therapeutics Series A round, September 2018: $9.3m
- TOLREMO therapeutics September 2017 Seed Funding Round: $2.6m
TOLREMO therapeutics September 2023 Series A Funding Round
$20m
TOLREMO therapeutics September 2023 Series A Funding Round
$20m
TOLREMO therapeutics June 2020 Series A Funding Round
$5.1m
TOLREMO therapeutics June 2020 Series A Funding Round
$5.1m
TOLREMO therapeutics September 2018 Series A Funding Round
$9.9m
TOLREMO therapeutics September 2018 Series A Funding Round
$9.9m
Tolremo Therapeutics Series A round, September 2018
$9.3m
TOLREMO therapeutics September 2017 Seed Funding Round
$2.6m
Industries
Tolremo Therapeutics is active in the following industries: